Antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) have been found in
some cases diagnosed as seronegative neuromyelitis optica spectrum disorder (NMOSD) …

Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple
sclerosis owing to unusual clinical or MRI findings or poor response to treatments used for …

There is a strong unmet clinical need for objective body fluid biomarkers to assist early
diagnosis and estimate long-term prognosis, monitor treatment response and predict …

Objective: To evaluate the effectiveness and tolerance of mycophenolate mofetil (MMF) as a
first-line treatment in neuromyelitis optica spectrum disorder (NMOSD). Methods: In all, 67 …

Background and purpose Neuromyelitis optica spectrum disorders (NMOSDs) are a group of
rare inflammatory demyelinating disorders of the central nervous system. The identification …

We aim to evaluate the clinical relevance of MOG-ab in a cohort of Chinese Han adults with
CNS inflammatory demyelinating diseases (IDDs). MOG-ab and AQP4-ab were examined …

Importance Neuromyelitis optica (NMO-including NMO spectrum disorders [NMOSD]) is a
devastating disease. Eighty-three percent of patients with transverse myelitic (TM) attacks …

Neuromyelitis optica (NMO) is an inflammatory and demyelinating disease of the central
nervous system. Although the prevalence of NMO is low, the rapid and severe impairment …

Neuromyelitis optica (NMO) is an autoimmune demyelinating disorder of the central nervous
system (CNS) with predilection for the optic nerves and spinal cord. Since its emergence in …

MS prevalence has been low but is increasing in Asia. In contrast, NMO/NMOSD prevalence
seems relatively constant in the world. Asian MS is not fundamentally different from Western …